Anti-tumoral effect of active immunotherapy in C57BL/6 mice using a recombinant human VEGF protein as antigen and three chemically unrelated adjuvants

Angiogenesis

Volumn 11, Issue 4, 2008, Pages 381-393

  Morera, Yanelys ^a   Bequet Romero, Mónica ^a   Ayala, Marta ^a   Lamdán, Humberto ^a   Agger, Else Marie ^b   Andersen, Peter ^b   Gavilondo, Jorge V ^a  

^a CENTER FOR GENETIC ENGINEERING AND BIOTECHNOLOGY   (Cuba)

^b STATENS SERUM INSTITUT   (Denmark)

Author keywords

Angiogenesis; Cancer; Immunotherapy; Vaccine; VEGF; VEGFR2

Indexed keywords

ADJUVANT; ALUMINUM HYDROXIDE; ANTIBODY; CAF 01; DIMETHYLDIOCTADECYLAMMONIUM BROMIDE; RECOMBINANT VASCULOTROPIN; UNCLASSIFIED DRUG; VERY SMALL SIZE PROTEOLIPOSOME;

ACTIVE IMMUNIZATION; ADJUVANT THERAPY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CD8+ T LYMPHOCYTE; CELL PROLIFERATION; CONTROLLED STUDY; ENDOTHELIUM CELL; ESCHERICHIA COLI; FEMALE; HUMAN; HUMAN CELL; LYMPHOCYTOTOXICITY; MELANOMA; MELANOMA CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEOLIPOSOME; RAT; SERUM; SURVIVAL; T LYMPHOCYTE; TUMOR; VACCINATION;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIBODIES; ANTIGENS; BEHAVIOR, ANIMAL; CD8-POSITIVE T-LYMPHOCYTES; CELL LINE, TUMOR; CELL PROLIFERATION; ENDOTHELIAL CELLS; ESCHERICHIA COLI; HUMANS; IMMUNE SERA; IMMUNOTHERAPY, ACTIVE; LYMPHOCYTE DEPLETION; MICE; MICE, INBRED C57BL; MUTANT PROTEINS; NEOPLASM TRANSPLANTATION; NEOPLASMS; RECOMBINANT PROTEINS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

ANIMALIA; MUS; RATTUS;

EID: 58149351409     PISSN: 09696970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10456-008-9121-5     Document Type: Article

References (37)

1. J Folkman 1985 Tumor angiogenesis Adv Cancer Res 43 175 203
2. J Folkman 2007 Angiogenesis: an organizing principle for drug discovery? Nat Rev Drug Discov 6 273 286
3. N Ferrara KA Houck LB Jakeman J Winer DW Leung 1991 The vascular endothelial growth factor family of polypeptides J Cell Biochem 47 211 218
4. HF Dvorak 2002 Vascular permeability factor/vascular endothelial growth factor: a critical cytokine in tumor angiogenesis and a potential target for diagnosis and therapy J Clin Oncol 20 4368 4380
5. N Ferrara 2005 VEGF as a therapeutic target in cancer Oncology 69 suppl 3 11 16
6. N Ferrara RS Kerbel 2005 Angiogenesis as a therapeutic target Nature 438 967 974
7. H Hurwitz L Fehrenbacher W Novotny 2004 Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer N Engl J Med 350 2335 2342
8. A Sandler R Gray MC Perry 2006 Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer N Engl J Med 355 2542 2550
9. K Miller M Wang J Gralow 2007 Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer N Engl J Med 357 2666 2676
10. JA Posey TC Ng B Yang 2003 A phase I study of anti-kinase insert domaincontainingreceptor antibody, IMC-1C11, in patients with liver metastases from colorectal carcinoma Clin Cancer Res 9 1323 1332
11. CB St C Rago V Velculescu 2000 Genes expressed in human tumor endothelium Science 289 1197 1202
12. YQ Wei QR Wang X Zhao 2000 Immunotherapy of tumors with xenogeneic endothelial cells as a vaccine Nat Med 6 1160 1166
13. XY Chen W Zhang W Zhang 2006 Vaccination with viable human umbilical vein endothelial cells prevents metastatic tumors by attack on tumor vasculature with both cellular and humoral immunity Clin Cancer Res 12 5834 5840
14. Y Okaji NH Tsuno J Kitayama 2004 Vaccination with autologous endothelium inhibits angiogenesis and metastasis of colon cancer through autoimmunity Cancer Sci 95 85 90
15. D Kamstock R Elmslie D Thamm S Dow 2007 Evaluation of a xenogeneic VEGF vaccine in dogs with soft tissue sarcoma Cancer Immunol Immunother 56 1299 1309
16. YQ Wei MJ Huang L Yang 2001 Immunogene therapy of tumors with vaccine based on Xenopus homologous vascular endothelial growth factor as a model antigen Proc Natl Acad Sci USA 98 11545 11550
17. M Bequet-Romero M Ayala BE Acevedo 2007 Prophylactic naked DNA vaccination with the human vascular endothelial growth factor induces an antitumor response in C57Bl/6 mice Angiogenesis 10 23 34
18. FH Rad BH Le S Paturance 2007 VEGF kinoid vaccine, a therapeutic approach against tumor angiogenesis and metastases Proc Natl Acad Sci USA 104 2837 2842
19. Y Li MN Wang H Li 2002 Active immunization against the vascular endothelial growth factor receptor flk1 inhibits tumor angiogenesis and metastasis J Exp Med 195 1575 1584
20. JY Liu YQ Wei L Yang 2003 Immunotherapy of tumors with vaccine based on quail homologous vascular endothelial growth factor receptor-2 Blood 102 1815 1823
21. J Pan A Heiser M Marget J Steinmann D Kabelitz 2005 Enhanced antimetastatic effect of fetal liver kinase 1 extracellular domain and interferon-gamma fusion gene-modified dendritic cell vaccination Gene Ther 12 742 750
22. Sambrok J, Fritsch EF, Maniatis T (1989) Molecular cloning: a laboratory manual, 2nd edn. Cold Spring Harbor Laboratory Press, Plainview, NY
23. D Yero R Pajon O Niebla 2006 Bicistronic expression plasmid for the rapid production of recombinant fused proteins in Escherichia coli Biotechnol Appl Biochem 44 27 34
24. EA Jaffe J Grulich BB Weksler G Hampel K Watanabe 1987 Correlation between thrombin-induced prostacyclin production and inositol trisphosphate and cytosolic free calcium levels in cultured human endothelial cells J Biol Chem 262 8557 8565
25. Y Morera H Lamdan M Bequet 2006 Biologically active vascular endothelial growth factor as a bacterial recombinant glutathione S-transferase fusion protein Biotechnol Appl Biochem 44 45 53
26. G Gonzalez T Crombet E Neninger C Viada A Lage 2007 Therapeutic vaccination with epidermal growth factor (EGF) in advanced lung cancer: analysis of pooled data from three clinical trials Hum Vaccin 3 8 13
27. BQ Shen DY Lee HP Gerber BA Keyt N Ferrara TF Zioncheck 1998 Homologous up-regulation of KDR/Flk-1 receptor expression by vascular endothelial growth factor in vitro J Biol Chem 273 29979 29985
28. Miller JH (1972) Experiments in molecular genetics. Cold Spring Harbor Laboratory Press, Plainview, NY
29. UK Laemmli 1970 Cleavage of structural proteins during the assembly of the head of bacteriophage T4 Nature 227 680 685
30. WN Burnette 1981 "Western blotting": electrophoretic transfer of proteins from sodium dodecyl sulfate-polyacrylamide gels to unmodified nitrocellulose and radiographic detection with antibody and radioiodinated protein A Anal Biochem 112 195 203
31. F Estevez A Carr L Solorzano 1999 Enhancement of the immune response to poorly immunogenic gangliosides after incorporation into very small size proteoliposomes (VSSP) Vaccine 18 190 197
32. J Davidsen I Rosenkrands D Christensen 2005 Characterization of cationic liposomes based on dimethyldioctadecylammonium and synthetic cord factor from M. tuberculosis (trehalose 6,6′-dibehenate)-a novel adjuvant inducing both strong CMI and antibody responses Biochim Biophys Acta 1718 22 31
33. AS Rosenberg 2006 Effects of protein aggregates: an immunologic perspective AAPS J 8 E501 E507
34. C Mesa LJ de K Rigley LE Fernandez 2004 Very small size proteoliposomes derived from Neisseria meningitidis: an effective adjuvant for Th1 induction and dendritic cell activation Vaccine 22 3045 3052
35. C Mesa LJ de LE Fernandez 2006 Very small size proteoliposomes derived from Neisseria meningitidis: an effective adjuvant for generation of CTL responses to peptide and protein antigens Vaccine 24 2692 2699
36. I Torrens O Mendoza A Batte 2005 Immunotherapy with CTL peptide and VSSP eradicated established human papillomavirus (HPV) type 16 E7-expressing tumors Vaccine 23 5768 5774
37. EB Lindblad MJ Elhay R Silva R Appelberg P Andersen 1997 Adjuvant modulation of immune responses to tuberculosis subunit vaccines Infect Immun 65 623 629